Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database

Clinical and Experimental Rheumatology

Volumn 33, Issue , 2015, Pages 75-79

  Sandmeier, Bettina ^a   Jäger, Veronika K ^a   Nagy, Gabriella ^b   Carreira, Patricia E ^c   Tzankov, Alexandar ^a   Widuchowska, Malgorzata ^d   Antic, Milos ^e   Distler, Oliver ^e   Reichert, Helena ^f   Distler, Jörg H W ^f   Walker, Ulrich A ^a   Hügle, Thomas ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF PÉCS   (Hungary)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Autopsy; EUSTAR; Mortality; Systemic sclerosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; IMATINIB; MYCOPHENOLIC ACID; PHOSPHODIESTERASE V INHIBITOR; PREDNISONE; PROSTACYCLIN; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; AUTOPSY; CASE STUDY; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; DYSPNEA; EUSTAR DATABASE; FEMALE; GASTROINTESTINAL DISEASE; HEART DISEASE; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; LUNG DISEASE; LUNG FIBROSIS; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASE; ORGAN SYSTEMS; PATIENT INFORMATION; PRIORITY JOURNAL; QUESTIONNAIRE; SKIN DISEASE; SYSTEMIC SCLEROSIS; VERY ELDERLY; CLINICAL TRIAL; COMPLICATION; DISEASE COURSE; EPIDEMIOLOGY; EUROPE; FACTUAL DATABASE; GASTROINTESTINAL TRACT; HEART MUSCLE; KIDNEY; LUNG; MORTALITY; MULTICENTER STUDY; MUSCULOSKELETAL SYSTEM; PATHOLOGY; PREDICTIVE VALUE; PREVALENCE; RETROSPECTIVE STUDY; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; CAUSE OF DEATH; DATABASES, FACTUAL; DISEASE PROGRESSION; EUROPE; FEMALE; GASTROINTESTINAL TRACT; HUMANS; KIDNEY; LUNG; MALE; MIDDLE AGED; MUSCULOSKELETAL SYSTEM; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 84946199972     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BARSOTTI S, BELLANDO RANDONE S, GUIDUCCI S, Della ROSSA A: Systemic sclerosis: a critical digest of the recent literature. Clin Exp Rheumatol 2014; 32 (Suppl. 86): S194-205.
2. JACOBSEN S, HALBERG P, ULLMAN S: Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 1998; 37: 750-5.
3. JOHN PA, IOANNIDIS M, PANAYIOTIS G et al.: Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005; 118: 2-10.
4. TYNDALL AJ, BANNERT B, VONK M et al.: Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69: 1809-15.
5. HESSELSTRAND R, SCHEJA A, AKESSON A: Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998; 57: 682-6.
6. MEUNE C, AVOUAC J, WAHBI K et al.: Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum 2008; 58: 1803-9.
7. PROUDMAN SM, STEVENS WM, SAHHAR J, CELERMAJER D: Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Intern Med J 2007; 37: 485-94.
8. FOLLANSBEE WP, CURTISS EI, MEDSGER TA et al.: Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984; 310: 142-8.
9. HUGLE T, van LAAR JM: Stem cell transplantation for rheumatic autoimmune diseases. Arthritis Res Ther 2008; 10: 217.
10. GOLDMAN L, SAYSON R, ROBBINS S, COHN LH, BETTMANN M, WEISBERG M: The value of the autopsy in three medical eras. N Engl J Med 1983; 308: 1000-5.
11. PIRILA L, SODERSTROM KO, HIETARINTA M, JALAVA J, KYTO V, TOIVANEN A: Fatal myocardial necrosis caused by Staphylococcus lugdunensis and cytomegalovirus in a patient with scleroderma. J Clin Microbiol 2006; 44: 2295-7.
12. BATTLE R, PATHAK D, HUMBLE C et al.: Factors influencing discrepancies between premortem and postmortem diagnoses. JAMA 1987: 339-44.
13. ROULSON J, BENBOW E, HASLETON P: Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review. Histopathology 2005: 551-9.
14. WALKER UA, TYNDALL A, CZIRJAK L et al.:. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007; 66: 754-63.
15. FERNANDES F, RAMIRES FJ, ARTEAGA E, IANNI BM, BONFA ES, MADY C: Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail 2003; 9: 311-7.
16. EICHER JC, BERTHIER S, AHO LS, LORCERIE B, BONNOTTE B, LAURENT G: Measurement of interatrial dyssynchrony using tissue Doppler imaging predicts functional capacity and cardiac involvement in systemic sclerosis. Clin Exp Rheumatol 2014; 32 (Suppl. 86): S171-6.
17. COOPER LT, BAUGHMAN KL, FELDMAN AM et al.: The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 2007; 28: 3076-93.
18. ALLANORE Y, MEUNE C, VONK MC et al.: Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010; 69: 218-21.
19. MEIER FM, FROMMER KW, DINSER R et al.: Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2012; 71: 1355-60.
20. ROBERTS NK, CABEEN WR, Jr., MOSS J, CLEMENTS PJ, FURST DE: The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis. Ann Intern Med 1981; 94: 38-40.
21. VD STEEN TAM: Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007: 940-4.
22. D'ANGELO WA, FRIES JF, MASI AT, SHULMAN LE: Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46: 428-40.
23. WELLS AU: High-resolution computed tomo-graphy and scleroderma lung disease. Rheumatology (Oxford) 2008; 47 (Suppl. 5): v59-61.
24. ROSEN O, MASSENKEIL G, HIEPE F et al.: Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy. Bone Marrow Transplant 2001; 27: 657-8.
25. van LAAR JM, NIHTYANOVA SI, NARAGHI K, DENTON CP, TYNDALL A: Autologous HSCT for systemic sclerosis. Lancet 2013; 381: 2079-80.
26. T. SCHMEISER PS, JIN D, NOETHE M et al.: ProWle ofgastrointestinal involvement inpatients withsystemic sclerosis Rheumatol Int 2012: 2471-8.
27. HØGH-OLESEN H: Human Morality and Sociality: Evolutionary and Comparative Perspectives. Basingstoke: Palgrave Macmillan; 2010; p. 274S.